AstraZeneca PLC
11778.00
18-February-25 10:29:56
15 minutes delayed
Stocks
+54.00
+0.46%
Today's range
11683.00 - 11844.00
ISIN
N/A
Source
Cboe
-
AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial
09 Nov 2023 02:55:26 By NASDAQ US Markets
-
AstraZeneca Q3 Pre-tax Profit Climbs; Lifts FY Outlook
09 Nov 2023 02:28:56 By NASDAQ US Markets
-
US FTC disputes listing for more than 100 patents in FDA Orange Book
07 Nov 2023 12:01:35 By NASDAQ US Markets
-
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
06 Nov 2023 13:44:08 By NASDAQ Stocks
-
AstraZeneca : Canada Approves Ultomiris For Adults With Neuromyelitis Optica Spectrum Disorder
01 Nov 2023 06:46:39 By NASDAQ US Markets
-
Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln
01 Nov 2023 04:05:04 By NASDAQ US Markets
-
Here’s Why You Could Be Giving Yourself—Or Someone Else—A Flu Shot Next Year
24 Oct 2023 07:18:46 By Forbes - World
-
AstraZeneca : FDA Accepts For Review SBLA For Self-administration Of Flumist Quadrivalent
24 Oct 2023 06:49:37 By NASDAQ US Markets
-
AstraZeneca : Enhertu Approved In EU For Advanced Non-small Cell Lung Cancer Treatment
23 Oct 2023 02:05:09 By NASDAQ US Markets
-
AZN : Imfinzi Combination Reduces Risk Of Disease Progression Or Death By 45% In Endometrial Cancer
21 Oct 2023 10:33:24 By NASDAQ US Markets